Global Institute Of Stem Cell Therapy And Research
US: (800) 969-4188 | Mexico: (619) 866-6000 | India: +91-8905483753

Category

News

Cranial reconstructions will soon be radicalized with the addition of 3D printing and stem cells into the method. A team of scientists from Western Australia will soon attempt this new technique with the intention of seeing the reduction in risk of complications, surgical procedure duration and costs.

The first patients will be those from the Royal Perth Hospital, whose skulls have either been severely damaged or partially removed for brain surgery.

human-skull

The research team, which includes a surgeon, two engineers, a neurosurgeon and chief scientist will collaborate with a Vienna-based 3D printing firm to replicate the bones from the patients’ cranium.

A printed bioceramic scaffold less than 100 microns (0.1mm) of the original bone will be infused with millions of stem cells. This will be fitted onto the patient’s skull.

This is the first time stem cells will be put to use with 3D printed scaffold to assist in bone regrowth, according to neurosurgeon Marc Coughlan.

“What we’re trying to do is take it one step further and have the ceramic resorb and then be only left with the patient’s bone, which would be exactly the same as having the skull back,” he said.

Health minister Kim Hames says,”This project highlights some of the innovative and groundbreaking research that is under way in WA’s public health system, and the commitment of the government to supporting this crucial work.”

The reconstruction project is part of the nine health and medical projects in Western Australia that has been allocated A$2 Million (US$1.5 Million) research funding grant by the state government. The government’s aim is to eventually reduce costs and improve efficiency in Australia’s public health service through the help of these projects.

Previous methods by past studies had the bone part frozen and stored for later replanting. However, attempts to replant often resulted either in infection or bone resorption. The more popular titanium plates, on the other hand, pose the problem of eventual material degradation.

Source : http://goo.gl/TJTLcT

Regenerative Medicine and Healthcare Risks: Risk Group Dialogue with Deven Patel

While a big-data revolution is under way in health care, there is also another silent revolution brewing in healthcare industry in the form of Regenerative Medicine.

In this session of Risk Roundup, Risk Group discusses Regenerative Medicine and Healthcare with GIOSTAR CEO Mr. Deven Patel, CEO, President & Cofounder at Global Institute of Stem Cell Therapy and Research (GIOSTAR) with headquarter in San Diego, California, U.S.A.

GIOSTAR CEO Mr. Deven Patel Visits Saudi Arabia

 

 

 

 

 

Neurol Res. 2012 Mar;34(2):129-42

Authors: Bednar MM, Perry A

Abstract
OBJECTIVE: Neurorestoration within the human central nervous system (CNS) is a concept that is barely a decade old. Despite this, there is significant clinical activity in this area, although there has not been any attempt to systematically identify these trials and organize them by disease area and phase of development. The objective of this investigation is to broadly review the current state of neurorestorative clinical trial activity ongoing worldwide.
METHODS: Iterative searches of the databases clinicaltrials.gov, EU Clinical Trials Register and ADIS Insight were used to locate clinical trials identified as involving neurorecovery/restoration strategies or stem cells for central nervous system diseases.
RESULTS: A wide range of neurorestorative clinical trials (N = 106) are ongoing or planned. Nearly three-fourths of all clinical trials (75/106) are targeting one of four disease areas: multiple sclerosis, stroke, Parkinson’s disease, and amyotrophic lateral sclerosis. Nearly two-thirds (63%) of 106 ongoing and planned clinical trials focus on cell-based therapy, although these are almost exclusively in phase 1 or 2 of development.
DISCUSSION: Neurorecovery is an emerging field that is currently focused on earlier stages of clinical development, primarily in four disease areas. As the field matures, it is expected that there will be a greater balance of studies across a wider spectrum of CNS diseases as well as in late-stage development.

PMID: 22333068 [PubMed – indexed for MEDLINE]

 

Related Articles

Gujarat awarded Prime Minister’s Civil Services Award for successfully tackling Sickle Cell Anemia in Gujarat

Sickle Cell Anaemia is the most common form of Sickle Cell Disease (SCD). SCD is a serious disorder in which the body makes sickle-shaped red blood cells. Sickle-shaped means that the red blood cells are shaped like a crescent. In Gujarat, this disease is prevalent in certain tribes. The State Government under the leadership of Honble Chief Minister is committed to improve the lives of marginalized people and weaker sections of society to bring them at par with rest of the people of the State. As a part of improving the lives of people especially tribals and in a bid to control the menace of disease which affects a very large tribal population of the state, the Government has taken various measures and also decided to set up Gujarat Sickle Cell Control Society. The Sickle Cell Anaemia Control Programme was started in four districts of South Gujarat in the year 2006 at the behest of Honble Chief Minister Shri Narendra Modi. The programme was later expanded to all 12 tribal districts of the State. Initially, 78 Government and NGO Institutions were involved in the programme from 4 tribal districts of South Gujarat. As of December 2010, there were 414 centres across the 12 tribal districts of that were involved in the comprehensive care of SCA patients.

The Government has taken up the challenging task of Mass Sickle Cell Screening of all 61.62 lakh tribal population of Gujarat within 5 years at a cost of Rs.24.76 crore. The Government of Gujarat also signed a MoU with GIOSTAR, a USA based company for creating stem cell faculties at the Government Medical College, Surat. Under this programme, more than 13 lakh tribal people benefited during last four years. This is an unique and a highly focused programme to tackle the problem of Sickle Cell Anemia in the tribal population of the State. A multi-pronged and comprehensive strategy was adopted. They were also provided necessary counseling. Marriage counseling was also done amongst youngsters. As a result, tremendous awareness is noticeable amongst tribal people of Gujarat by way of their participation in prenatal diagnosis and new born screening program, thereby reducing morbidity and mortality as a result of this genetic disorder. In fact, to improve the lives of tribal people and bring them at par with rest of the population in the State, Honble Chief Minister has launched a Rs.15,000 crore Van Bandhu Yojana for implementation during 11th Five Year Plan (2007-2012). During last 10 years, Gujarat is acknowledged as a State which has planned and implemented a number of excellent initiatives which have solved the problems of the State and these initiatives have become model for rest of the country. Some of the schemes/models have been recognized internationally by Commonwealth and United Nations.

Source

Make An Enquiry

We are here to help you

WordPress Video Lightbox